You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company has entered into an agreement with the shareholders of Discover Echo to acquire all outstanding shares to a purchase price of USD 110 million. Approximately eleven percent of the purchase price will be paid in newly issued shares of series B in CELLINK and the remaining part will…
A new Norwegian clinical pilot will investigate how women can receive more personalized breast cancer screening. “This ‘one size fits all’ approach does not take into account the different breast cancer risks of individual women. A more personalised screening program might be beneficial forAlready a subscriber Login You have read…
In October 2021, Finnish startup Surgify's bone cutting technology was taken into use on patients at Helsinki University Hospital. “The two surgical patients recovered well from their surgeries and returned home quickly. Neither faced soft tissue damage during the operation,” says Head of HUSAlready a subscriber Login You have read…
AstraZeneca and Medimmune, AstraZeneca PLC’s global biologics research and development unit, gave a presentation on the company’s pipeline in the area of immuno-oncology at the recent American Society of Clinical Oncology meeting. Immuno-oncology involves programming or stimulating the bodyAlready a subscriber Login You have read all your free articles, to continue reading…
